🔬 FDA loosens CAR-T rules, Lilly pre-empts tariffs, Novo stops Wegovy deal, FDA CDER chief resigns, Nektar drug soars, Vor Bio deal, Cidara flu drug succeeds, Compass Pathways dilution, Illumina buys, AstraZeneca/Daiichi drug OK'd, Sanofi licenses, Novo Nordisk AI, Kymera-Gilead, Plus Therapeutics wins, childhood vaccination plateau, Novartis buys Regulus, CDC panel questions vaccines, Acadia pipeline, WHO Gaza aid, BioCryst sells, Altimmune drug misses.